Recent Finacing
Recent Raise
Nob Hill Therapeutics develops the patent‑protected DryNeb dry‑powder nebulizer and inhaled anti‑infective therapeutics that deliver high-dose aerosols to the lower respiratory tract independent of patient lung capacity.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Nob Hill Therapeutics.
